Share Name Share Symbol Market Type Share ISIN Share Description
Proximagen Neuroscience LSE:PRX London Ordinary Share GB00B06FMX57 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 365.25p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.2 -7.2 -10.7 - 209.59

Proximagen Neuroscience Share Discussion Threads

Showing 51 to 71 of 75 messages
Chat Pages: 3  2  1
DateSubjectAuthorDiscuss
01/4/2016
20:49
For my own reference more than anything else - hTTp://adisinsight.springer.com/drugs/800035713 Most Recent Events 15 Feb 2016 Phase-II development in Osteoarthritis is ongoing in United Kingdom (PO) 01 Dec 2015 PRX 167700 licensed to Roche worldwide 19 Jul 2013 Phase-II clinical trials in Osteoarthritis in United Kingdom (PO)
elgordo
22/7/2015
13:35
In case anyone out there is interested... I have just got hold of the CVR Representative’;s annual update for 2014, issued in March 2015. (These updates are supposed to be issued to holders annually, but I had not seen previous ones and had considerable trouble getting hold of this one – maybe that’s just a problem I’m having?) In summary, the potential value from the CVRs was derived from two programmes, and their status is as follows: PRX00993 – dead and buried (“discontinued”). PRX-167700 – Active partnering discussions on back of progress and headline results of Phase IIa osteoarthritis study and planning for IBD clinical studies. “In January 2015 a potential partner proposed terms for supporting Phase II clinical study with an option for commercial rights. Discussions are continuing with this potential partner as well as other potential partners.” So, still some hope of value to be derived from the CVRs, though I believe they expire at the end of August 2017 so time is starting to run quite short.
elgordo
09/8/2012
12:17
Farewell then, Proximagen. I decided to hold on for the CVRs - any value that comes through from them will be a nice bonus down the line.
elgordo
19/6/2012
17:46
I have always rated the management here, a sound investment IMO.
mike111d
19/6/2012
12:15
A great result. Any other holders out there with thoughts on whether better to sell into the market, or take the 320p and the CVRs? Should have a good few weeks to decide, and the implied value of the CVRs appears to be creeping upwards... I'm minded to gamble that Upsher-Smith's confidence in acquiring the VAP-1 and PRX00933 programs will convert into successful commercialisation down the line, but if the share price moves up further there will be a point where it becomes clearly better to take the money now. What I have no way of assessing is where that point lies.
elgordo
14/6/2012
06:59
yep. nothing like insider info :-)
pugg1ey
13/6/2012
06:44
LOL, now we know why these had been rising sharply recently, held these a few years back under a quid I think, doh!
charmer1_23
14/5/2012
09:05
I sold out at 180p and thought I had banked a nice profit ;-) If locaserin gets the nod this increases the value of PRX's own 5-HT2c program which is in phase 2 and looking to go to phase 3?
pugg1ey
14/5/2012
08:58
What's the story here then folks, shares have taken off sharply in the last few trading sessions but little discussion here. Regards :=)
charmer1_23
05/3/2012
11:10
Boom, i'm in SCLP post that post, many thanks for this
thedickster
01/2/2012
15:59
lol. not surprised noone interested in such an illiquid stock but chance of a takeover here, maybe?
pugg1ey
01/2/2012
12:15
mms moving up on just a 2K buy
pugg1ey
26/1/2012
16:37
bought some just before the close. something going on here(in a good way for the SP) imo
pugg1ey
24/1/2012
18:33
Up over 11% today, with around 9% of the company changing hands, and no comment? Just how under the radar is this?
elgordo
22/12/2010
12:27
Yes well done to the BOD, another good year for PRX.
mike111d
22/12/2010
11:32
http://www.stockopedia.co.uk/research/proximagen-group-lonprx-gsk-assets-acquired-51613/
chingman
06/8/2010
11:07
http://www.stockopedia.co.uk/research/a-done-deal-45854/
chingman
06/1/2010
17:21
ElGordo: Will you wake me up when there`s any news?.......Zzzzzzzzz!
bobt5940
05/1/2010
10:44
Looks like I was wrong about this board "livening up" once PRX announced an acquisition. Admittedly a small deal (and, as far as I can figure, not at a significant premium to MDM's cash balances - £4.3m v £3.5m), but nice to see some activity here.
elgordo
12/11/2009
10:20
Proximagen expands http://www.growthcompany.co.uk/news/1088357/proximagen-expands.thtml
investinggarden
04/11/2009
20:30
Wow, it really is quiet here, isn't it? Clearly the CBT acquisition was too minor to attract any interest. I guess things will liven up when PRX announces its first major acquisition using some of its £50m war chest.
elgordo
Chat Pages: 3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20161209 05:49:45